
Coventry Group Limited (ASX: CYG) Stock Analysis: Small-Cap Mailbag
Is Coventry Group (ASX: CYG) a good ASX small-cap stock to invest in? Our short stock analysis of Coventry Group is provided at the request of a reader.
Is Coventry Group (ASX: CYG) a good ASX small-cap stock to invest in? Our short stock analysis of Coventry Group is provided at the request of a reader.
The company demonstrated everything I had hoped to see in this set of results, with earnings per share up 15%.
Is Veem (ASX: VEE) a good ASX small-cap stock to invest in? Here is a short stock analysis of Veem, provided at the request of a reader.
Dropsuite grew revenue more than 30% in H1 FY 2024, but this impressive organic growth came at the expense of the bottom line.
Hub24 (ASX: HUB) continues to gain market share and grow profits, and it has the lofty earnings multiple to match.
Steadfast (ASX: SDF) presented record results, but has the share price run too far?
Supply Network management does not talk much but they absolutely walk the walk.
Net profit before tax was up 71% to $10.2 million.
SiteMinder (ASX: SDR) made a loss in FY 2024 but there are signs the business is improving in quality.
Profit before tax was down 10%, but if you accept the company’s various “one off” adjustments, it was up 10%.
A couple of delayed contracts muted growth, but free cashflow was extraordinarily strong.
Evaluating the Kip McGrath Education Centre (ASX: KME) FY 2024 Results.
Vysarn (ASX: VYS) grew profit before tax at over 50% in FY 2024 (and profit after tax growth was even better).
REA Group (ASX: REA) is going really well in Australia where it dominates already, but success is far from certain in India, where it hopes to grow.
Directors have been buying shares in Silk Logistics Holdings (ASX: SLH) at around current levels.
Audinate (ASX: AD8) continues to smash the competition, and the Audinate share price is recovering from being smashed by negative outlook.
A strong performance in FY 2024 saw earnings and dividends per share come in slightly above what I’d been hoping for.
The Pro Medicus (ASX: PME) share price gained more than 8% after it reported another set of strong results, beating analyst estimates.
Supporters can request we look at any company under $2b market capitalisation, as part of our small-cap mailbag series.